Skip to main content
VCbacked
Log inGet Started

Anodyne Chemistries

Vancouver, Canada

Anodyne is a carbon utilization company, transforming CO2 into carbon negative products for a climate positive future

$6.0M raised
May 2026
Grant
BiotechnologyChemicalCleanTech

Top Investors

Plug and PlayGovernment of CanadaNorthX Climate TechAgriculture and Agri-Food CanadaCanaccord Genuity

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Anodyne Chemistries

How much funding has Anodyne Chemistries raised?
Anodyne Chemistries has raised $6.0M in total funding. The most recent round was Grant. The last funding was announced in May 2026.
Who are Anodyne Chemistries's investors?
Anodyne Chemistries's investors include Plug and Play, Government of Canada, NorthX Climate Tech, Agriculture and Agri-Food Canada, Canaccord Genuity.
Where is Anodyne Chemistries headquartered?
Anodyne Chemistries is headquartered in Vancouver, Canada.
What does Anodyne Chemistries do?
Anodyne is a carbon utilization company, transforming CO2 into carbon negative products for a climate positive future
What stage is Anodyne Chemistries at?
Anodyne Chemistries is at the Grant stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Anodyne Chemistries — Funding & Investors." VCBacked, May 26, 2026, https://www.vcbacked.co/company/anodyne-chemistries. Accessed June 3, 2026.
APA
VCBacked. (2026). Anodyne Chemistries — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/anodyne-chemistries
Wikipedia (cite web)
{{cite web |title=Anodyne Chemistries — Funding & Investors |url=https://www.vcbacked.co/company/anodyne-chemistries |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong